{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:04Z","timestamp":1761540604099},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1053\/j.jvca.2004.11.002","type":"journal-article","created":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T17:18:09Z","timestamp":1108487889000},"page":"4-10","source":"Crossref","is-referenced-by-count":42,"title":["Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients"],"prefix":"10.1053","volume":"19","author":[{"given":"Susan B.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Renna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward L.","family":"Spitznagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Avidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Charles W.","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benico","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rao","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Despotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2004.11.002_bib1","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1053\/hj.1999.v138.a102299","article-title":"The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory","volume":"138","author":"Deutsch","year":"1999","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2004.11.002_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2004.11.002_bib3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0735-1097(00)00648-3","article-title":"Low molecular weight heparin in acute coronary syndrome","volume":"35","author":"Kaul","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2004.11.002_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0003-4975(00)01343-6","article-title":"Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb\/IIIa blockade. Evaluation of Platelet IIb\/IIIa Inhibition in STENTing","volume":"70","author":"Lincoff","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib5","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0002-8703(97)70014-0","article-title":"Rationale for low-molecular weight heparin in coronary stenting","volume":"134","author":"Zidar","year":"1997","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2004.11.002_bib6","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.99.15.1951","article-title":"Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb\/IIIa blockade with abciximab: One-year outcome in the EPILOG trial. Evaluation in PTCA to improve long-term outcome with abciximab GP IIb\/IIIa blockade","volume":"99","author":"Lincoff","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.103.10.1403","article-title":"Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.CIR.102.1.28","article-title":"Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb\/IIIa inhibition in complex atherosclerotic lesions","volume":"102","author":"Cura","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0735-1097(98)00551-8","article-title":"Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary thrombosis-II","volume":"33","author":"Tardiff","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2004.11.002_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archsurg.133.4.442","article-title":"Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors. Northern New England Cardiovascular Disease Study Group","volume":"133","author":"Dacey","year":"1998","journal-title":"Arch Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.97.6.562","article-title":"Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery","volume":"97","author":"van de Watering","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.97.17.1680","article-title":"Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb\/IIIa receptor blockade","volume":"97","author":"Mascelli","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5223(97)70414-8","article-title":"Tirofiban provides \u201cplatelet anesthesia\u201d during cardiopulmonary bypass in baboons","volume":"113","author":"Hiramatsu","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0003-4975(98)00527-X","article-title":"Integrilin prevents prolonged bleeding times after cardiopulmonary bypass","volume":"66","author":"Suzuki","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-129-5-199809010-00009","article-title":"The antiplatelet effects of ticlopidine and clopidogrel","volume":"129","author":"Sharis","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2004.11.002_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.160.2.181","article-title":"A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism","volume":"160","author":"Dolovich","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2004.11.002_bib17","first-page":"5212B","article-title":"Bleeding with coronary artery bypass surgery (CABG) in patients treated with a platelet glycoprotein IIb\/IIIa inhibitor","volume":"29","author":"Tardiff","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"suppl E","key":"10.1053\/j.jvca.2004.11.002_bib18","first-page":"E14","article-title":"Low-molecular-weight heparin therapy in percutaneous coronary intervention: The NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators","volume":"12","author":"Young","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.jvca.2004.11.002_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0003-4975(97)01299-X","article-title":"Abciximab and excessive bleeding in patients undergoing emergency cardiac operations","volume":"65","author":"Gammie","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0028-1086129","article-title":"Alterations of hemostasis associated with cardiopulmonary bypass","volume":"3","author":"Bick","year":"1976","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2004.11.002_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00000542-199909000-00042","article-title":"Preoperative use of enoxaparin and tirofiban","volume":"91","author":"Skubas","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2004.11.002_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-5223(98)70296-X","article-title":"Emergency coronary bypass grafting for failed percutaneous coronary artery stenting","volume":"115","author":"Alvarez","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0003-4975(99)01366-1","article-title":"Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery","volume":"69","author":"Clark","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib24","first-page":"139","article-title":"Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate","volume":"16","author":"Massonnet-Castel","year":"1986","journal-title":"Haemostasis"},{"key":"10.1053\/j.jvca.2004.11.002_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-5223(98)70057-1","article-title":"Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons","volume":"116","author":"Gikakis","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib26","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0022-5223(96)70158-7","article-title":"Cardiopulmonary bypass for heparin-induced thrombocytopenia: management with a heparin-bonded circuit and enoxaparin","volume":"112","author":"Ganjoo","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1010-7940(00)00404-8","article-title":"Undergoing cardiopulmonary bypass using enoxaparin only during a cardiac transplantation procedure","volume":"17","author":"Prifti","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-5223(96)70380-X","article-title":"Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations","volume":"111","author":"Moulton","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-5223(94)70481-3","article-title":"Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation","volume":"107","author":"Despotis","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl 1","key":"10.1053\/j.jvca.2004.11.002_bib30","first-page":"I19","article-title":"Preoperative use of enoxaparin compared to unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open heart surgery in patients who present with an acute coronary syndrome","volume":"106:12","author":"Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2004.11.002_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0003-4975(99)01132-7","article-title":"Emergency coronary artery bypass graft surgery in abciximab-treated patients","volume":"69","author":"Lemmer","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(84)91429-6","article-title":"Low-molecular-weight heparin in extracorporeal circulation","volume":"1","author":"Massonnet-Castel","year":"1984","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2004.11.002_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-5223(99)70227-8","article-title":"Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass","volume":"118","author":"Shigeta","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2004.11.002_bib34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/00000542-199706000-00021","article-title":"The effects of heparinase 1 and protamine on platelet reactivity","volume":"86","author":"Ammar","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2004.11.002_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1051\/ject\/200133294","article-title":"Effects of ultrafiltration on enoxaparin","volume":"33","author":"Kohtz","year":"2001","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2004.11.002_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/s-0037-1615609","article-title":"Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans","volume":"85","author":"Schick","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2004.11.002_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsre.1996.0261","article-title":"A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation","volume":"63","author":"Wakefield","year":"1996","journal-title":"J Surg Res"},{"key":"10.1053\/j.jvca.2004.11.002_bib38","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(99)01264-7","article-title":"Pharmacological strategies to decrease excessive blood loss in cardiac surgery","volume":"354","author":"Levi","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2004.11.002_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(98)12494-7","article-title":"Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery","volume":"354","author":"Despotis","year":"1999","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/j.jvca.2004.11.002_bib40","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00001721-200004001-00023","article-title":"Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery","volume":"11","author":"Al Douri","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2004.11.002_bib41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00000539-199710000-00031","article-title":"Low molecular weight heparin","volume":"85","author":"Horlocker","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2004.11.002_bib42","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/00000542-200005000-00055","article-title":"Does perioperative antithrombotic therapy increase the likelihood of a postoperative coagulopathy after cardiac surgery?","volume":"92","author":"Lewis","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2004.11.002_bib43","first-page":"1361","article-title":"Enoxaparin","year":"2001","journal-title":"Quebecor World"},{"key":"10.1053\/j.jvca.2004.11.002_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00001721-199410000-00018","article-title":"Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers","volume":"5","author":"Holst","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2004.11.002_bib45","series-title":"A Course in Nonparametric Statistics","author":"Hajek","year":"1969"},{"key":"10.1053\/j.jvca.2004.11.002_bib46","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/0002-9149(94)90474-X","article-title":"Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation prevention of ischemic complications","volume":"74","author":"Boehrer","year":"1994","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077004002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077004002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:21:29Z","timestamp":1706008889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077004002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1053077004002733"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2004.11.002","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}